Cargando…

Exosomes Derived from CXCR4-Overexpressing BMSC Promoted Activation of Microvascular Endothelial Cells in Cerebral Ischemia/Reperfusion Injury

BACKGROUND: Ischemic stroke is a severe acute cerebrovascular disease which can be improved with neuroprotective therapies at an early stage. However, due to the lack of effective neuroprotective drugs, most stroke patients have varying degrees of long-term disability. In the present study, we inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xutong, Zhang, Ye, Wang, Yong, Zhao, Dan, Sun, Chengcheng, Zhou, Shaoting, Xu, Dongsheng, Zhao, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762674/
https://www.ncbi.nlm.nih.gov/pubmed/33381162
http://dx.doi.org/10.1155/2020/8814239
Descripción
Sumario:BACKGROUND: Ischemic stroke is a severe acute cerebrovascular disease which can be improved with neuroprotective therapies at an early stage. However, due to the lack of effective neuroprotective drugs, most stroke patients have varying degrees of long-term disability. In the present study, we investigated the role of exosomes derived from CXCR4-overexpressing BMSCs in restoring vascular function and neural repair after ischemic cerebral infarction. METHODS: BMSCs were transfected with lentivirus encoded by CXCR4 (BMSC(CXCR4)). Exosomes derived from BMSC(CXCR4) (Exo(CXCR4)) were isolated and characterized by transmission electron microscopy and dynamic light scattering. Western blot and qPCR were used to analyze the expression of CXCR4 in BMSCs and exosomes. The acute middle cerebral artery occlusion (MCAO) model was prepared, Exo(CXCR4) were injected into the rats, and behavioral changes were analyzed. The role of Exo(CXCR4) in promoting the proliferation and tube formation for angiogenesis and protecting brain endothelial cells was determined in vitro. RESULTS: Compared with the control groups, the Exo(CXCR4) group showed a significantly lower mNSS score at 7 d, 14 d, and 21 d after ischemia/reperfusion (P < 0.05). The bEnd.3 cells in the Exo(CXCR4) group have stronger proliferation ability than other groups (P < 0.05), while the CXCR4 inhibitor can reduce this effect. Exosomes control (Exo(Con)) can significantly promote the migration of bEnd.3 cells (P < 0.05), while there was no significant difference between the Exo(CXCR4) and Exo(Con) groups (P > 0.05). Exo(CXCR4) can further promote the proliferation and tube formation for the angiogenesis of the endothelium compared with Exo(Con) group (P < 0.05). In addition, cobalt chloride (COCl2) can increase the expression of β-catenin and Wnt-3, while Exo(Con) can reduce the expression of these proteins (P < 0.05). Exo(CXCR4) can further attenuate the activation of Wnt-3a/β-catenin pathway (P < 0.05). CONCLUSIONS: In ischemia/reperfusion injury, Exo(CXCR4) promoted the proliferation and tube formation of microvascular endothelial cells and play an antiapoptotic role via the Wnt-3a/β-catenin pathway.